Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1

被引：17

作者：

Donners, H ^{[1
]}

Willems, B ^{[1
]}

Beirnaert, E ^{[1
]}

Colebunders, R ^{[1
]}

Davis, D ^{[1
]}

vanderGroen, G ^{[1
]}

机构：

[1] Inst Trop Med, Dept Microbiol, Virol Lab, B-2000 Antwerp, Belgium

来源：

AIDS | 2002年 / 16卷 / 03期

关键词：

D O I：

10.1097/00002030-200202150-00030

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：501 / 503

页数：3

共 6 条

[1]

Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt

[2]

14::AID-JMV3&gt

[3]

3.0.CO

[4]

2-L

[5] Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients [J].

Burrer, R ;

Salmon-Ceron, D ;

Richert, S ;

Pancino, G ;

Spiridon, G ;

Haessig, S ;

Roques, V ;

Barre-Sinoussi, F ;

Aubertin, AM ;

Moog, C .

JOURNAL OF VIROLOGY, 2001, 75 (11) :5421-5424

[6] Multivariate analysis of human immunodeficiency virus type 1 neutralization data [J].

Nyambi, PN ;

Nkengasong, J ;

Lewi, P ;

Andries, K ;

Janssens, W ;

Fransen, K ;

Heyndrickx, L ;

Piot, P ;

vanderGroen, G .

JOURNAL OF VIROLOGY, 1996, 70 (09) :6235-6243

← 1 →